Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Little Rock Allergy & Asthma Clinic (LRAAC) is a specialized clinic conducting clinical research on new treatments for allergies, asthma, urticaria, influenza, hereditary angioedema, and COPD. Since 2000, LRAAC has completed over 170 clinical trials, often in partnership with major pharmaceutical companies such as Novartis and CSL Behring. The clinic is active in Phase 2 and Phase 3 studies for novel therapies in allergic and respiratory diseases, but is not a biotechnology or pharmaceutical company—it is a clinical research site and medical practice.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Little Rock Allergy & Asthma Clinical Research Center.